INTRODUCTION
Tibrogargan virus (TIBV) was initially isolated from a pool of Culicoides brevitarsis midges near Peachester in southeastern Queensland, Australia in 1976, and later from the blood of a healthy bovine (Cybinski & Gard, 1986; Cybinski et al., 1980; St George, 2002) . Coastal Plains virus (CPV) was isolated from the blood of an asymptomatic steer more than 3000 km away at the Coastal Plains Research Station (currently known as Beatrice Hill), Northern Territory, Australia in 1981 (Cybinski & Gard, 1986) . Examination by electron microscopy places these viruses in the family Rhabdoviridae. Serological tests show they are antigenically distinct members of the same serogroup and demonstrate no close relationships to any other known rhabdovirus with the exception of Bivens Arm virus (BAV), which was isolated from water buffalo in Florida, USA (Calisher et al., 1989; Cybinski & Gard, 1986; Gibbs et al., 1989; Tesh et al., 1983) .
More than 3000 cattle sera collected during the 1970s and 1980s from sentinel herds located throughout Australia and New Guinea were tested for neutralizing antibodies against TIBV and CPV (Cybinski & Gard, 1986; Cybinski et al., 1980) . The viruses were found to have similar distributions throughout northern Australia and New Guinea, spanning a large region from the central Western Australian coast to the central New South Wales coast. This area corresponds with the known distribution of C. brevitarsis (Cybinski & Gard, 1986; Cybinski et al., 1980) , suggesting a role for C. brevitarsis as a vector for both viruses. Many herds tested were up to 100 % seropositive for these viruses (Karabatsos, 1985) . During testing for seroconversion of cattle herds to TIBV, animals were observed for the development of signs of illness; no illness was observed however. Conclusive studies to determine the role of TIBV and CPV in disease remain to be performed (Cybinski et al., 1980) . CPV displays a potentially broader range of hosts than TIBV because, in addition to cattle and buffalo, neutralizing antibodies to this virus have also been found in 9/51 dogs, 1/73 horses and 1/1 goat. Although deer are highly susceptible to feeding by C. brevitarsis, there is no evidence of antibodies in deer to either virus (St George, 2002) . Sera from humans, pigs and wallabies from the vicinity of CPV-seropositive cattle also tested negative (Cybinski & Gard, 1986 ).
Prior to our study, no genetic data for CPV was available, and the only available genetic data for TIBV was a highly conserved 408 nt fragment of the L polymerase gene, which was generated through a phylogenetic study assessing the relationships of nine of the 17 previously unsequenced Australian rhabdoviruses. The study showed that TIBV belongs to the diverse dimarhabdovirus supergroup which consists of two recognized genera, Ephemerovirus and Vesiculovirus, and numerous unassigned viruses, many of which were isolated in Australia (Bourhy et al., 2005) . The majority of viruses from this supergroup are assumed to be arthropod transmitted. It was suggested that TIBV had a considerably distant relationship from all the dimarhabdoviruses in the study. Its closest relatives are Le Dantec virus (LDV) and Fukuoka virus (FUKAV) of the Le Dantec group, which have been associated with illness in humans and cattle, respectively, in Africa (Cropp et al., 1985; Noda et al., 1992) .
To enable an accurate assessment of TIBV and CPV at the genetic level, full genomic sequencing of both viruses was undertaken. Phylogenetic comparisons were performed with other rhabdoviruses and comparisons of the predicted secondary structure elements of the three novel putative proteins found in both viruses were performed. A study of the seroprevalence of TIBV and CPV in livestock and a variety of Australian wildlife species was performed over the period [1993] [1994] [1995] [1996] [1997] [1998] [1999] [2000] [2001] [2002] [2003] [2004] [2005] [2006] [2007] .
RESULTS AND DISCUSSION
Unique genome structure of TIBV and CPV The complete genomes of TIBV and CPV are 13 298 and 13 203 nt in size, respectively. Both viruses encode the typical five rhabdovirus proteins nucleoprotein (N), phosphoprotein (P), matrix protein (M), glycoprotein (G) and viral RNA polymerase (L), and, in addition, both viruses contain two further putative genes: one between M and G and one between G and L. TIBV contains an additional small ORF overlapping the G gene, and like several other rhabdoviruses CPV contains an additional ORF overlapping the P gene (Fig. 1) .
Although the prototype animal rhabdovirus genome contains only five structural proteins (N, P, M, G and L), numerous additional novel genes have been discovered in a number of vertebrate rhabdoviruses. Examples include bovine ephemeral fever virus (BEFV) and Adelaide River virus (ARV) from the genus Ephemerovirus, the unassigned Flanders virus (FLAV), tupaia rhabdovirus (TUPV), Wongabel virus (WONV) and Ngaingan virus (NGAV) (Gubala et al., 2008 (Gubala et al., , 2010 McWilliam et al., 1997; Springfeld et al., 2005; Walker et al., 1992; Wang & Walker, 1993; Wang et al., 1994) . The distantly related fish viruses of the genus Novirhabdovirus are also known to contain an additional gene between the G and L genes, and plant-infecting rhabdoviruses contain up to four genes or ORFs between the P and M genes (Dietzgen et al., 2006; Huang et al., 2003; Reed et al., 2005; Revill et al., 2005; Scholthof et al., 1994; Tanno et al., 2000) . Until recently, when the animal rhabdoviruses FLAV, TUPV, WONV and NGAV were found to contain genes between the P and M and M and G genes, the location of novel genes in animal rhabdoviruses had only been observed between the G and L genes. TIBV and CPV share a characteristic genome structure not previously reported for any rhabdovirus as they contain three additional genes, two between M and G and one between G and L. Fig. 1 . Organization of the TIBV and CPV genomes. The typical rhabdovirus ORFs N, P, M, G and L are depicted by hollow arrows. Each virus contains three related novel ORFs (U1, U2 and U3; depicted as grey arrows). In addition, TIBV contains a small ORF (U4) that overlaps the G gene and CPV contains a small ORF (P9) that overlaps the P gene (black arrowheads). The predicted transcription strategy for each virus is indicated by the black arrows. The dashed arrow depicts a possible bicistronic U1-U2 transcript in CPV.
Transcription/replication N, P and L proteins and the envelope-associated M and G proteins
The N proteins of rhabdoviruses are typically the most highly conserved. In TIBV and CPV the N proteins share 67 % identity, the highest sequence homology of all the proteins (Table 1 ). The P proteins are often the most highly divergent of all of the rhabdovirus proteins. In TIBV and CPV the P proteins share relatively high sequence identity (41 %), and comparison of predicted a-helices, and b-loops and sheets indicates a fundamentally similar secondary structure. Similarly to the vesiculoviruses, BEFV and the unclassified NGAV, CPV contains an additional small ORF overlapping P (designated P9) encoding a putative small 33 aa protein with a pI of 10.7, which is most similar in size and pI to the Piry virus (Vesiculovirus) C protein, a nonstructural accessory protein (Kretzschmar et al., 1996; Peluso et al., 1996; Spiropoulou & Nichol, 1993) . These nonessential proteins assist vesiculoviruses and paramyxoviruses by altering the host immune response through suppression of apoptosis, regulation of transcription and replication, and assist in virus budding (Irie et al., 2008; Kretzschmar et al., 1996; Nagai & Kato, 2004; Peluso et al., 1996) . In contrast, TIBV does not contain an ORF that overlaps with P despite the high similarity of the two proteins. The L proteins of TIBV and CPV have an overall amino acid identity of 55 %.
The M proteins of TIBV and CPV share 40 % amino acid identity. Both proteins contain the conserved virus buddingassociated L-domain motifs PPXY and PT/SAP, which are highly conserved in many animal rhabdoviruses (CPV, PPDY and PSAP; TIBV, PPLK and PTAP, respectively) (Chen & Lamb, 2008; Harty et al., 1999) . The TIBV M protein contains a distinguishing run of six serine residues near the amino terminus, the role of which is unknown. The G proteins of both viruses (56 % amino acid identity) contain characteristics typical of rhabdovirus G proteins: an amino-terminal signal peptide, an ectodomain, a transmembrane region and a cytoplasmic tail. The signal peptide cleavage site for CPV is predicted to be at residue 21, whereas varying predictions are made for the TIBV signal peptide (PHOBIUS, no signal peptide; neural networks algorithm, residue 16; hidden Markov model, residue 24). The ectodomains are predicted to follow the signal peptides up to residue 587 in both viruses, and are followed by transmembrane domains at residues 588-605, followed by a 57 aa (TIBV) and a 53 aa (CPV) cytoplasmic tail. A distinguishing feature of the TIBV/CPV G proteins is the size of their globular domains, which are larger by 20-40 aa than those of all other dimarhabdoviruses. Each G protein is predicted to contain nine N-glycosylation sites. There is, overall, high conservation of the location of a-helices, b-sheets and loops in TIBV and CPV, when compared with BEFV and vesicular stomatitis Indiana virus (VSIV), suggesting overall conservation of secondary structure.
Rhabdovirus G proteins typically contain 10-18 conserved cysteines that form disulphide bonds and play an important role in the folding of the globular domains (Roche et al., 2006 (Roche et al., , 2007 Thornton, 1981; Walker, 2008; Walker & Kongsuwan, 1999) . It has been proposed that the locations of these cysteines form patterns that can be used to distinguish viruses from different genera and can be used to assign new viruses into genera (Walker & Kongsuwan, 1999) . The TIBV and CPV G proteins share conservation of eight of the nine cysteine pairs found in the genus Ephemerovirus; they lack the 'J' pair, but instead contain an additional cysteine pair located in the outmost region of the globular domain (cysteine residues 433 and 447 in each virus) (Roche et al., 2006 (Roche et al., , 2007 Walker & Kongsuwan, 1999 ). This appears to be a new bond not previously observed in any animal rhabdovirus. According to the model of conserved cysteine pairing, TIBV and CPV contain a new pattern and consequently may belong to a new genus.
Comparisons of novel TIBV and CPV proteins
The five structural proteins of TIBV and CPV share a high sequence identity overall, ranging between 67 and 40 %. In contrast, the novel putative proteins U1, U2 and U3 are significantly more divergent than the five structural proteins are.
The U1 proteins share approximately 29 % amino acid identity and the majority of a-helices, b-sheets and loops are highly conserved (Fig. 2a) . The CPV U1 protein is predicted to contain a signal peptide at residues 1-23, but one is not apparent in TIBV U1. A nucleotide conflict was observed in CPV U1 at position 3204 in a significant proportion of the sequences analysed (noted in the GenBank entry), causing a premature termination of translation generating a shorter 66 aa polypeptide instead of the complete 173 aa protein.
This may be because of adaptation of the virus in cell culture, wherein the full-length U1 protein may not be required or it may occur due to genetic diversity within the virus stock. A highly conserved section of 28 aa occurs in the central region of each protein (residues 90-117) (Figs 2a and 3), but the sequence that follows this region displays high divergence in terms of sequence and predicted secondary structure.
Of the three unknown proteins, the U2 proteins share greatest sequence similarity (35 % aa identity) ( Table 1) . These proteins are predicted to contain an N-glycosylation site and an N-myristoylation site in almost identical locations (Fig. 3) . TIBV U2 is predicted to contain an 'endoplasmic reticulum localization signal' (KKXX) at the carboxy terminus; however, no signal peptide, which is required to direct proteins to the endoplasmic reticulum for Nglycosylation to occur, has been identified on either protein.
Consequently, the likelihood of glycosylation is not certain. Like the U1 proteins, overall the U2 proteins also show high conservation of secondary structural elements (Fig. 2b ).
For proteins that share only 19 % sequence identity (the lowest similarity of all the proteins), the U3 proteins are predicted to have distinctly similar secondary structures. Each is predicted to contain a long a-helix domain interrupted by a short sheet-loop structure (Fig. 2b ). These long a-helices correspond, approximately, to the predicted transmembrane domains (Fig. 3) . Other characterizing features include signal-peptide cleavage sites located within the helix domains of both proteins, each immediately followed by a cysteine residue (TIBV, residue 53; CPV, residue 43) (Fig. 3) . In CPV U3, a predicted 'prokaryotic membrane lipoprotein lipid attachment site' is located adjacent to the cleavage site, which is represented by the characteristic motif LYIIVILVAGC (residues 33-43) (Fig. 3) .
In TIBV, an additional putative 168 nt ORF (U4) occurs within the predicted G transcript. It overlaps the end of the G ORF and extends into the 64 nt 39 UTR of the G gene, similar to the putative 384 nt WONV putative viroporin (Gubala et al., 2008) . This ORF encodes a small 55 aa protein that contains a highly hydrophobic 21 aa transmembrane-like domain proximal to the amino terminus. BLAST searches suggest that the protein shares 51 % similarity with a part of a Paramecium tetraurelia hypothetical protein. Although the high level of similarity between these two proteins could be coincidental, owing to the small size of U4, the high level of homology could be indicative of a conserved functional domain.
Although the collective implication of the observations made for the novel TIBV and CPV proteins is not yet known, the significant level of conservation of secondary structure elements indicates conservation of biological functions.
Owing to the high degree of sequence divergence, it appears that their biological functions are reliant on secondary structure rather than on sequence conservation.
Importantly, the similarities between these proteins are supporting evidence that they are indeed expressed and are functional.
The prediction of roles for novel proteins is hindered by lack of supporting functional data and this is an area of rhabdovirus research that requires greater attention. It has been postulated that novel proteins may have accessory roles during infection (McWilliam et al., 1997; Wang et al., 1994) . Several novel proteins found in rhabdoviruses (including BEFV, ARV, WONV, FLAV, TUPV and NGAV) have been identified as containing characteristics typical of viroporins (Gubala et al., 2008 (Gubala et al., , 2010 McWilliam et al., 1997; Springfeld et al., 2005; Wang et al., 1994) . Viroporins are small proteins that form pores in cell membranes and facilitate the passage of ions and small molecules to create a favourable environment during infection (Gonzalez & Carrasco, 2003) . The U3 proteins of TIBV and CPV are candidate viroporins; this is based on their size, the presence of transmembrane domains and the presence of numerous highly basic residues (lysine and arginine) following the transmembrane domain (Gonzalez & Carrasco, 2003) . The small 55 aa U4 protein in TIBV, which contains a region resembling a transmembrane domain in proximity to the amino terminus, is likewise a candidate viroporin.
The method through which novel genes arise in rhabdoviruses remains unclear, but gene duplication is suspected to be one of the means (Walker et al., 1992; Wang & Walker, 1993) . Although the probability of recombination occurring in negative-sense ssRNA viruses is believed to be low, recent crystallographic studies of the vesicular stomatitis virus (VSV) G protein have revealed an unexplained structural similarity with the herpesvirus gB protein (Roche et al., 2006) . This has ignited the hypothesis that perhaps Mononegavirales are indeed capable of obtaining foreign genes by recombination.
It is important to note that these viruses have been passaged in cell culture a number of times and the original material from midges and bovines (from 1981 and 1976 
Phylogenetic analyses
Prior to our study, the only available sequence information for TIBV was a 408 nt fragment of the L gene (Bourhy et al., 2005) . In that study TIBV was placed as the type virus of the Tibrogargan group, which clustered most closely with the Le Dantec group consisting of LDV and FUKAV (viruses which have been associated with febrile illness in human, and fever and leukopenia in calves, respectively) (Cropp et al., 1985; Noda et al., 1992) . Until our study, no sequence data were available for CPV. The relationship of TIBV and CPV to the Le Dantec group cannot be confirmed until further sequencing is performed on the Le Dantec group.
Phylogenetic analyses of N and G proteins in this study show that TIBV and CPV form an independent monophyletic cluster within the Rhabdoviridae (Fig. 4) . Analysis of the N protein (Fig. 4a) suggests that TIBV and CPV are considerably more closely related to the ephemeroviruses than found previously using the short L gene fragment (Bourhy et al., 2005) . If interpreted alone, these data could erroneously indicate that TIBV and CPV belong to the genus Ephemerovirus. This, however, is not supported by the G protein phylogenetic analysis (Fig. 4b) , which demonstrates that TIBV and CPV have a considerably more distant relationship to the ephemeroviruses, which is suggestive of a new genus. Although this is supported by a considerably lower bootstrap value (45/100), lower bootstrap values of rhabdovirus G proteins probably reflect the greater divergence of these proteins and limited number of sequences available for comparison. Currently, all viruses within the genus Ephemerovirus contain a second glycoprotein (G NS ), and this is one of the requirements for the classification of viruses into this genus (Tordo et al., 2005) . Neither TIBV nor CPV contain a second glycoprotein and their genome structures are considerably different from the ephemeroviruses. It is clear that there is significant divergence between the TIBV/CPV viruses and the ephemeroviruses and that they cannot be placed into this genus under the current criteria. To accommodate TIBV and CPV the revision of the family will either need modification of the current criteria for assigning new viruses into the genus Ephemerovirus (possibly by the creation of a subgenus), or the creation of a new genus.
Transcription control sequences and non-coding regions
Both viruses have perfectly conserved transcription start signals for all genes (AACAG) but there are two variants of the transcription stop/poly(A) signal in TIBV, and six variants in CPV (see Supplementary Table S1 , available in JGV Online, for transcription control sequences of both viruses). Variation is not atypical in viruses from the dimarhabdovirus supergroup; significant variation has been observed in WONV and NGAV and could be suggestive of 'leaky' transcription stop signals, which could be a means for regulating the transcription of monocistronic or polycistronic mRNAs (Gubala et al., 2008 (Gubala et al., , 2010 Wang & Walker, 1993) . Typically poly(A) signals contain a run of seven adenosine residues (A 7 ), but the TIBV M poly(A) signal contains eight and the CPV U1 poly(A) signal contains only six residues, which, according to observations for VSV, probably results in polymerase read-through or abolition of polyadenylation, which would suggest synthesis of a bicistronic U1-U2 mRNA transcript (Barr et al., 1997) . Alternatively, the A 6 tract could be responsible for decreased reiterative transcription of the poly(A) tail, resulting in a lower abundance of polyadenylated mRNA transcripts. However, a small proportion of analysed sequences for CPV U1 contained the required seven adenosines, suggesting that the A 6 tract may have occurred as a result of adaptation to cell culture or may be representative of genetic variation within the virus sample.
An unusually long 107 nt intergenic region between the U3 and L genes occurs in CPV, which, by comparison, consists of only 2 nt in TIBV. This long intergenic region could influence the transcription efficiency of the polymerase gene by forcing the polymerase to scan over a long nontranscribed region. This region could be a remnant of an ancestral gene, as has been proposed for the 423 nt G-L intergenic region in RABV (Tordo et al., 1986) , or it could be an artefact of the gene duplication or recombination process through which U3 arose (Walker et al., 1992; Wang & Walker, 1993) .
The putative TIBV U2 gene contains a 78 nt 39 UTR and the G gene contains a 55 nt 59 UTR, which suggests the presence of an unusually long 136 nt stretch of non-coding sequence. A 114 nt ORF is located in reverse orientation neatly within this non-coding region. Since encoding proteins by means of reverse ORFs has never been previously described in a rhabdovirus and does not conform with the current understanding of genetic processes within this family, this ORF is probably irrelevant.
Leader and trailer sequences
The leader sequences of CPV and TIBV are 46 and 51 nt, and the trailer sequences are 209 and 164 nt, respectively. High conservation of inverse complementarity of genome termini (typically between the terminal 15-20 nt at both termini) is a common feature among rhabdoviruses, and this is the case in both genomes. Both viruses also contain the three terminal nucleotides (59-ACG/CGT-39) that are perfectly conserved amongst mammalian rhabdoviruses.
Serological prevalence of TIBV and CPV in livestock
In the 1970s and 1980s serological surveys indicated that TIBV and CPV were widely distributed in cattle throughout northern Australia, within the known distribution range of C. brevitarsis, which is suspected to play a role in the life cycle of these viruses (Cybinski et al., 1980) . TIBV and other rhabdoviruses (including BEFV) have been isolated from Culicoides, spp. therefore it has been suggested that midges could be vectors, but the role of midges as effective rhabdovirus vectors remains uncertain (St George, 2002) .
To determine whether TIBV is currently circulating in the Australian environment, a set of 1657 sera collected from various animals in the Northern Territory between 1993 and 2007 was screened for exposure to TIBV using a virus neutralization test (VNT). The animals tested were sentinel cattle, sentinel buffalo, farmed and feral pigs, birds (including poultry), macropods (wallabies, kangaroos and wallaroos) and a small set of horses, reptiles and rodents.
Following initial screening of all sera at 1 : 5 dilution, it became apparent that antibodies against TIBV were found predominantly in cattle (35/277) and buffalo (64/280). Low-level neutralization was also found in one feral pig, one bird and one wallaby. Further studies were performed with the positive cattle sera and, following titration using twofold dilutions up to a maximum dilution of 1 : 80, 25/ 35 cattle sera had titres between 10 and 80.
The positive cattle sera originated from a sentinel herd scheme from three locations in the Northern Territory (see Supplementary Table S2 and Supplementary Fig. S1 for a location map; both of these are available in JGV Online). Table S3 , available in JGV Online,). As in previous years, a similar proportion of cattle tested positive (18.6 %). Cattle from the year with the highest prevalence of positive animals (2004; 10/24 cattle, 42 %) were selected for detailed testing of the development of neutralizing antibodies over their entire 11 month residence at BHF (Supplementary Table S4 , available in JGV Online,). Two animals (50 and 64) neutralized TIBV with high titres at the pre-bleed, suggesting exposure to the virus prior to arrival at the farm, which was assumed to have occurred at the location where the cattle were born and reared before arriving at BHF (either Douglas Daly Research Farm or the Victoria River Research Station, approximately 100 km and 220 km south-west of BHF, respectively).
By April 2004, which coincides with the end of the monsoon season, the majority of animals (8/10) neutralized TIBV. This pattern is typical of arthropod-transmitted viruses in northern Australia and supports the theory that TIBV is arthropod-transmitted. Antibody titres fluctuated over the time period for all animals (dropping below the level of detection for animal 63 in March), which possibly suggests restimulation of the immune system through reinfection.
Previous indirect immunofluorescence and crossneutralization studies using heterologous and homologous antisera generated against TIBV and CPV in rabbits showed that these viruses cross-neutralize (titre of 16) (Cybinski & Gard, 1986) . The same study demonstrated cross-neutralization by 11/26 cattle sera; it also showed that 5/26 neutralized CPV only and 3/26 neutralized TIBV only. Our study aimed to extend these findings by screening a larger selection of cattle sera (n5118) concurrently for both viruses (Supplementary Table S3 ).
Of 118 cattle tested, 14 animals tested positive for both viruses, 18 to CPV only and eight to TIBV only. Although these data could be suggestive of cross-reactivity, the extent of this is not clear because it is not possible to exclude the possibility of an animal being simultaneously infected with both viruses, or with another related virus, without additional studies. There is at least one other virus, BAV, which is known to be closely related to TIBV (Gibbs et al., 1989) .
Initially it was thought that BAV was introduced into Florida from Trinidad via imported water buffalo, but it was found later that it was prevalent in cattle before the importation date. Antibody titres of cattle in Florida were often very high for TIBV, sometimes considerably higher for TIBV than BAV, suggesting a close antigenic relationship or perhaps co-existence of different viruses, perhaps some that remain to be isolated (Gibbs et al., 1989) . The study suggested that TIBV-related viruses are spread throughout the world and possibly have an ancestry in Asia where the water buffalo is native. The presence of BAV in Australian cattle remains unknown and testing for it would be valuable. The sequencing of BAV would contribute significantly to the understanding of relationships between these three viruses.
The lack of observed disease in cattle as a result of infection with TIBV and CPV could be because of a long-established and stable co-existence of virus and host. Some of the consequences of climate change could include changes in vector or host distribution and adaptation, and subsequent transmission of virus to new hosts. This could potentially have immense impacts. It would therefore be pertinent to initiate monitoring for the spread of these viruses to other animal species and new geographical locations. Although VNT is a very useful and simple preliminary approach for determining virus exposure in animals, the problem of cross-neutralization between different rhabdoviruses is likely to result in inaccurate estimation of virus prevalence. This is probably not uncommon amongst other less well understood rhabdoviruses. Tests that are more specific, such as nucleic acid-based detection tests, are necessary for more accurate differentiation.
Concluding remarks
The position of TIBV and CPV should be clarified within the family Rhabdoviridae either by the creation of a new genus or by changing the demarcation criteria of the genus Ephemerovirus. Although the roles and relationships of novel putative proteins found in a growing list of rhabdoviruses are not yet sufficiently resolved, they may need to play a more significant role in rhabdovirus classification. Currently the resolution of the taxonomy of the dimarhabdovirus supergroup is complicated and cannot be simplified until additional viruses, representing the different types of genome structure, are sequenced and studied.
METHODS
Virus propagation, RNA extraction and genomic sequencing.
TIBV (strain CS132), CPV (strain DPP53) and BEFV (strain CS1927; passage history unknown) were propagated in BHK-BSR cells (a subclone of the bady hamster kidney BHK-21 cell line) at 37 uC. To generate the sufficient amount of RNA recommended for use in the PCR-select cDNA-subtraction technique (2 mg), infected cell culture supernatant from 66150 cm 2 flasks was ultracentrifuged at 4 days post-inoculation, following the development of cytopathic effect, as previously described (Gubala et al., 2010) . BEFV was used as the driver in the PCR-select cDNA subtractions. To obtain sequence data for TIBV, a modified PCR-select cDNAsubtraction method was used with three different restriction enzymes (RsaI, AluI and HaeIII) in combination with highthroughput 454 sequencing (Roche), as previously described (Gubala et al., 2010) . Sequence data for CPV was obtained by the traditional approach of using only one restriction enzyme (RsaI), then cloning fragments into pCR-Blunt II-TOPO and sequencing them conventionally (Gubala et al., 2008) . The sequences generated for both viruses were assembled into contiguous sequences, which were subsequently used to design primer pairs to amplify sequences that consecutively overlapped and covered the entire genome of each virus, as described previously (Gubala et al., 2008) .
3 § and 5 § RACE. A modified RACE method was used to obtain the terminal genome sequences, as previously described (Gubala et al., 2010) . For TIBV the single PCR primer for the 39 terminus (genome locations indicated in parentheses) was 59-TTGTTCCAAACCGACA-TACG-39 (699-718) and the cDNA synthesis, primary and secondary PCR primers for the 59 terminus were 59-CGCAATCATCAACAAAC-AAGTG-39 (12 792-12 813), 59-CAAGTTGGCAACAATTGGACAG-39 (12 930-12 951) and 59-AGGTAATCCGGAGTTGTG-39 (12 950-12 967), respectively. For CPV the primary and secondary PCR primers for the 39 terminus were 59-AAACAGTGGCTCTATGTTG-39 (515-533) and 59-TGGCCAAACGATAAATTGC-39 (482-500), respectively, and the cDNA synthesis/primary and secondary PCR primers for the 59 terminus were 59-GCCTTCAAATACACCAATATC-39 (12 605-12 625) and 59-CTTTAAT-TGGGCAAGTGATTC-39 (12 764-12 784), respectively. RACE PCRs were performed by using these primers and a modified rhabdovirus-specific anchor primer (Gubala et al., 2010) . PCR products were purified using a QIAquick PCR Purification kit (Qiagen) and sequenced directly by using the virus-specific primers.
DNA sequencing and sequence analyses. Routine sequencing was performed using a BigDye Terminator v1.1 kit and the ABI PRISM 3130xl Genetic Analyzer (both from Applied Biosystems) according to the manufacturer's protocols. Sequencing of the TIBV genetic material was performed by using a 454 Life Sciences Sequencer (Roche) . Sequence assembly and routine sequence management were performed by using the programs SeqMan Pro version 8.0.2 (DNASTAR), CLONE MANAGER version 9 (Sci Ed Central) and ARTEMIS (Rutherford et al., 2000) . Sequence similarity searches of GenBank/EMBL and Swiss-Prot databases were performed using BLAST (http://www.ncbi.nlm.nih.gov) (Altschul et al., 1997) . Amino acid sequence identity levels of deduced TIBV and CPV proteins as compared to equivalent proteins from other members of the family Rhabdoviridae were determined from CLUSTAL W pairwise alignments using MEGALIGN version 7.2.1 (DNASTAR). Protein sequences were analysed by using PredictProtein (http:// www.predictprotein.org) (Rost et al., 2004) , ProtScale and SignalP programs, which are available at the ExPASy Proteomics Server (http:// au.expasy.org), and PHOBIUS (http://phobius.cbr.su.se/). Phylogenetic analyses were performed by using programs available through BioManager at the ANGIS web interface (http://biomanager. info). CLUSTAL W alignments of selected proteins were edited manually at both ends to minimize gaps and ensure maximum compatibility. N protein alignments were trimmed considerably to enable the incorporation of unassigned rhabdoviruses for which complete N sequences are not yet available, as previously described (Kuzmin et al., 2006) . Evolutionary relationships were estimated using the distance matrix method (PROTDIST) and neighbour-joining phylogenetic trees were drawn using TreeView version 1.6.6 (Page, 1996) . Bootstrap resampling (100 replicates) was performed using SEQBOOT to confirm the statistical reliability of the phylogenetic trees.
VNT. Serum samples from various animal species were screened by using a VNT to assess the samples for antibodies to TIBV and CPV, as previously described (Gubala et al., 2010) . Following initial screening of all sera at a 1 : 5 dilution, twofold series dilutions (1 : 10, 1 : 20. 1 : 40 and 1 : 80) of each positive serum were performed in duplicate or quadruplicate using the same procedure. For selected sera, dilutions up to 1 : 1280 were performed to determine end-point titre values. Serum neutralization titres were calculated using the 50 % end point method of Reed & Muench (1938) . 
